Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M198Revenue (TTM) $M4.4Net Margin (%)-2,650.3Altman Z-Score-6.5
Enterprise Value $M105EPS (TTM) $-3.2Operating Margin %-2,667.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.2Pre-tax Margin (%)-2,650.3Higher ROA y-yY
Price/Book2.010-y EBITDA Growth Rate %-14.1Quick Ratio3.9Cash flow > EarningsY
Price/Sales47.25-y EBITDA Growth Rate %-10.5Current Ratio3.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-61.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-72.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M38.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with DVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAXJohn Paulson 2016-06-30 Reduce$13.2 - $22.74
($17.12)
$ 5.15-70%Reduce -12.87%174,000
DVAXJohn Paulson 2016-03-31 Add0.01%$16.12 - $29.7
($20.26)
$ 5.15-75%Add 49.25%199,700
DVAXJohn Paulson 2015-12-31 Buy 0.02%$22.08 - $27.9
($25.09)
$ 5.15-79%New holding133,800
DVAXGeorge Soros 2012-06-30 Sold Out -0.03%$35.2 - $52.6
($42.76)
$ 5.15-88%Sold Out0
DVAXGeorge Soros 2012-03-31 Reduce-0.09%$32.8 - $50.3
($40.41)
$ 5.15-87%Reduce -62.50%37,500
DVAXGeorge Soros 2011-12-31 Buy 0.14%$18.2 - $33.3
($28.15)
$ 5.15-82%New holding100,000
DVAXGeorge Soros 2011-09-30 Sold Out -0.0026%$18.4 - $31.6
($24.39)
$ 5.15-79%Sold Out0
DVAXGeorge Soros 2011-06-30 Buy 0.0026%$24.6 - $28.1
($26.35)
$ 5.15-80%New holding6,610
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Janssen RobertVice President 2016-06-28Buy1,452$13.68-63.82view
Gray EddieCEO and Director 2016-05-20Buy2,750$15.57-68.21view
Janssen RobertVice President 2016-05-12Buy1,000$15.12-67.26view
Janssen RobertVice President 2015-10-08Buy100$23.34-78.79view
Gray EddieCEO and Director 2014-08-14Buy2,500$14.9-66.78view
KISNER DANIEL LDirector 2013-10-30Buy1,000$10.8-54.17view
ORONSKY ARNOLD LDirector 2013-10-30Buy18,605$10.8-54.17view
Phillips Peggy VDirector 2013-10-30Buy9,302$10.8-54.17view
Janssen RobertChief Medical Officer and VP 2013-07-09Sell0$0-54.17view
Novack David FSenior Vice President 2013-03-25Sell0$0-54.17view

Press Releases about DVAX :

Quarterly/Annual Reports about DVAX:

News about DVAX:

Articles On GuruFocus.com
Trump Victory Gives Life to Pharma,Biotech - Take a Look at VBI Vaccines Nov 11 2016 
Steven Cohen Increases Position in Dynavax Oct 07 2016 
VBI Vaccines: The Safer Alternative to the Struggling Dynavax Technologies Sep 06 2016 
William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
Two Promising Health Care Stocks with Market Capitalizations Under $500 Million Jun 11 2014 
Top Three Largest Insider Buys of the Past Week Nov 05 2013 
Steven Cohen, George Soros, John Paulson All Add to Holdings Mar 07 2012 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Aug 02 2010 
Dynavax Technologies Corp. Reports Operating Results (10-Q) May 10 2010 
Price % Loser Stocks of The Day: SIGA Technologies Inc., Universal Travel Group, U.S. Concrete Inc., Dec 10 2009 

More From Other Websites
7:01 am Dynavax announces clinical data from an ongoing Phase 1/2 trial of a combination of SD-101... Dec 05 2016
Dynavax Presents Clinical Data from Lead Cancer Immunotherapy Candidate, SD-101, in Combination with... Dec 05 2016
5 Stocks Poised for Major Breakouts--Gold, Pharma and Tech Dec 04 2016
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax... Dec 02 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in... Dec 02 2016
Why These 3 Healthcare Stocks Lost Half Their Value in November Dec 01 2016
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax... Dec 01 2016
Lifshitz & Miller Law Firm Announces Investigation of Cempra, Inc., Commvault Systems, Inc., Dakota... Dec 01 2016
Dynavax to Webcast Cancer R&D Day on December 9, 2016 Dec 01 2016
Dynavax to Present Clinical Data from Immuno-oncology Product Candidate, SD-101 Dec 01 2016
Dynavax to Webcast Cancer R&D Day on December 9, 2016 Dec 01 2016
Dynavax to Present Clinical Data from Immuno-oncology Product Candidate, SD-101 Nov 30 2016
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against... Nov 29 2016
ETFs with exposure to Dynavax Technologies Corp. : November 29, 2016 Nov 29 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against... Nov 29 2016
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax... Nov 28 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dynavax Technologies Corporation of... Nov 28 2016
Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 Nov 28 2016
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who... Nov 27 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in... Nov 25 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)